BioChange

Pioneering biotech company advancing regenerative medicine through innovative solutions for tissue repair and organ recovery.

Health Tech & Life Sciences
Active
Seed Yokne'am Illit, Israel Founded 2017
Last updated 2026-07-26
Total raised
$3.0M
Last: Undisclosed Round 2023-07
Stage
Seed
Founded
2017
Headcount
16
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences

About

BioChange is a pioneering biotech company dedicated to advancing regenerative medicine. They focus on developing innovative solutions for tissue repair and organ recovery, leveraging their proprietary CellFoam™ technology. This technology provides a natural protein foam scaffold that supports cell growth and tissue repair, with applications in both veterinary and human medicine. The company aims to address unmet medical needs and improve overall well-being by developing products that facilitate natural healing processes. BioChange is driven by a team of scientists, medical experts, and industry professionals, and holds a robust portfolio of 21 granted patents and 17 pending patents. Their innovative technology has already gained traction in the U.S.A. market, where their veterinary product line is successfully transforming animal care. They are also preparing to launch their dental human product in the near future.

Funding history · 3 rounds · $3.0M total

2023-06
Undisclosed Round $3.0M
★ quadraScope
2021-09
Undisclosed Round Undisclosed
★ ExitValley
2017-07
Grant $50K

Headcount over time

From 2 (2020-04) to 16 (2026-07) · +14 (+700%) · 31 points · source: Finder history + radar grounding
170 2020-04 2026-07

Q&A

What is BioChange's primary focus in the biotech industry?
BioChange is a pioneering biotech company dedicated to advancing regenerative medicine, focusing on developing innovative solutions for tissue repair and organ recovery using their proprietary CellFoam™ technology.
When was BioChange founded?
BioChange was founded in 2017.
How many employees does BioChange currently have?
BioChange has 11-50 employees.
What is BioChange's total funding to date?
BioChange has raised a total of $18,000,000 USD.
What is BioChange's core technology?
BioChange's core technology is CellFoam™, a natural protein foam scaffold that supports cell growth and tissue repair.
What is the current status of BioChange's product development?
BioChange's veterinary product line is successfully transforming animal care in the U.S.A. market, and they are preparing to launch their dental human product in the near future.
How many patents does BioChange hold?
BioChange holds a robust portfolio of 21 granted patents and 17 pending patents.

Team · 1

Ishay Attar
Founder · Founder, Chairman & CEO

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesCosmeticsHealthcareProvidersConsumersRecreational & LifestylePet Owners
Business model
B2B

Highlights

1 PatentsVerified

Tags

biodegradabledogspet-ownerstreatmentsbiotechnologytissue-regenerationdoctorsmedical-devicesminimally-invasiveregenerative-medicinemedical-technologiesveterinarydermatologyurology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitebiochange.life/?v=4605f628f91d
LinkedInlinkedin.com/company/64981522
Facebookfacebook.com/BioChange.life
YouTubeyoutube.com/watch?v=F9rSRGz0aXk

Identifiers & details

Legal nameBio-Change Ltd.
Founded2017
Employees (exact)16

Radar intelligence

Patents

EPO1

Publications (Crossref)

Works10

Web history (Wayback)

Domainbiochange.life

Certificate / subdomain footprint

Subdomains27

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)514903749
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2013-04-02
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Last annual report2025
Active charges / liens0
Registry events0
Registered addressהיצירה 13 יקנעם עילית